An interventional study of New PPE and Old PPE in Covid19 and Personal Protective Equipment, sponsored by University of Oxford. Completed at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2021-01-15.
Sponsored by University of Oxford · Not applicable, Interventional, and Prevention
This study aims to improve the personal protective equipment (PPE) used while treating patients with COVID-19, to protect staff and avoid cross-infection of patients. Protecting staff from infection during the Covid pandemic is critical to maintaining health services. Mistakes in using protective equipment (PPE) are the commonest avoidable factor in staff becoming infected at work. Recently, intensive care doctors have also reported an increase in the spread of dangerous multi-resistant bacteria between patients, which appears likely to be transmitted between patients by Level 2 PPE worn by staff (specifically gown sleeves). This study therefore seeks to develop and test a new protocol to decrease cross-infection risks whilst using Level 2 PPE.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 67 is below the median of 100 across 4,099 interventional studies indexed under COVID-19.
Browse COVID-19 studies →University of Oxford is the lead sponsor of 794 studies on the registry; 117 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Use of Short sleeve gown and single pair of gloves
Other: New PPE
Use of Long sleeve gown and double pairs of gloves
Other: Old PPE
The use of a new protocol of level 2 PPE which involves wearing a short-sleeve gown and a single pair of gloves
The use of a standard protocol of level 2 PPE which involves wearing a long-sleeve gown and double pairs of gloves
Proportion of participants and simulated patients with contamination as assessed by ultraviolet light
The primary outcome of this study is the proportion of participants and simulated patients who were contaminated with fluorescent powder as examined under a UV light, using a response of "YES" or "NO", when participants wore new (experimental) Level 2 PPE in comparison to the standard (control) Level 2 PPE
Time frame: immediately after simulations
Participants' perception of personal comfort and safety and safety of the patients as assessed through structured questionnaire
We will measure the participants' perception of personal comfort and safety and the safety of the patient when wearing experimental versus control Level 2 PPE, during simulation tasks, using a 10 point Likert scale response to a structured questionnaire
Time frame: immediately before simulations and immediately after simulations
changes in participants perception of personal comfort and safety and safety of patients as assessed through a semi-structured questionnaire
We will measure changes in participants perception of their personal comfort and safety and the safety of patients when wearing each type of PPE using a semi-structured interview (a) before the PPE training, (b) after the PPE training, and (c) after the simulation training exercises.
Time frame: immediately before training, immediately after training and immediately after simulation
The difference in the area of contamination between New and Standard PPE as analyzed through python script
we will perform a quantitative analysis of the area of contamination of participants and simulated patients and assess the difference between when participants wore new (experimental) Level 2 PPE and the standard (control) Level 2 PPE, using pre-coded functions with python script.
Time frame: immediately after simulations
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Oxford